GlassScriptPhysician profile
Sarah Borges
NPI 1689569972
$1,258.65
in general payments reported to CMS, 2019-2025
16 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $217.27 | 2025 | Rexulti |
| Abbvie INC. | $204.55 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $147.45 | 2025 | Farxiga, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $142.86 | 2025 | Caplyta |
| Novo Nordisk INC | $83.21 | 2025 | Wegovy, Ozempic, Rybelsus |
| Verona Pharma, INC. | $76.74 | 2025 | Ohtuvayre |
| Glaxosmithkline, LLC. | $51.85 | 2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Alnylam Pharmaceuticals INC. | $50.00 | 2025 | Onpattro |
| Lilly USA, LLC | $45.21 | 2025 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $43.04 | 2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $43.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.32 | 2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $39.42 | 2025 | Eliquis, Camzyos |
| Tolmar, INC. | $38.57 | 2025 | Jatenzo |
| Insightec,INC | $17.93 | 2025 | Exablate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $17.23 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Borges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.